drugset / Trial / NCT03824808

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

NCT03824808 ↗

Phase 4 Terminated 21 enrolled University of Missouri-Columbia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Controlling pain is fundamental during and after surgical procedures. This study examines pain associated with robotic assisted surgery on prostate cancer or a kidney mass. In recent years, the risk of opioids in the postoperative period has gained interest due to the growing epidemic of addiction, dependence, and overdose. In this study, the investigators expect a continuous infusion of intravenous lidocaine during the perioperative period to result in less pain and less opioid use.

Timeline

Start
2019-02-26
Primary completion
2020-03-26
Completion
2020-03-26

Outcome

Outcome not reported

Stopped (Enrollment): “Challenges with recruitment of surgical research subjects in the target population.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 0.5 mg/kg Intravenous
Comparator Lidocaine Other / unclassified 0.8 % Intravenous
Comparator Lidocaine Other / unclassified 1 mg/kg Intravenous